ClinicalTrialsFinder

HER2 Negative Breast Neoplasms Clinical Trials in Cheongju-si, North Chungcheong

1 recruitingCheongju-si, North Chungcheong, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer1,006 enrolled154 locationsNCT04389632